Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 - Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results
Related Keywords
Switzerland , Pratteln , Switzerland General , Eva Kalias , Head Investor Relations Communications , Santhera Pharmaceuticals Holding , Santhera Pharmaceuticals , Annual Report , General Meeting , Head Investor Relations , Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.